Designing Smart Clinical Trials

15 Apr 2024 4:30 p.m. 5:30 p.m.
Hall D
DebbieGipson Chairperson United StatesNational Institutes of Health/NIDDK
JonathanBarratt Chairperson United KingdomUniversity of Leicester, Leicester, UK
Add to My Schedule

Session Description:
In this session, several aspects important for designing clinical trials will be highlighted.
Learning Objectives:
Understand the importance of sub phenotyping, and the potential of AI tools, and predictive biomarkers in designing clinical trials.

Time Session
4:30 p.m.
4:45 p.m.
Patients Subphenotyping: The Example of Diabetic Kidney Disease
John CijiangHe Speaker cijiang.he@mssm.eduUnited StatesIcahn School of Medicine at Mount Sinai
4:45 p.m.
5 p.m.
Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease
LauraMariani Speaker lmariani@umich.eduUnited StatesUniversity of Michigan
5 p.m.
5:15 p.m.
Targeted Approaches in Clinical Trial Design
HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands
5:15 p.m.
5:30 p.m.
Q and A